SLC9B1 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-56493
Key Product Details
Species Reactivity
Human
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed against a recombinant protein corresponding to the following amino acid sequence: VLYTMVLQENGYGVEEDIPTLLMAAS
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for SLC9B1 Antibody
Immunocytochemistry/ Immunofluorescence: SLC9B1 Antibody [NBP2-56493]
Immunocytochemistry/Immunofluorescence: SLC9B1 Antibody [NBP2-56493] - Staining of human cell line REH shows localization to microtubule organizing center.Applications for SLC9B1 Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
0.25-2 ug/ml
Application Notes
Immunocytochemistry/Immunofluorescence Fixation Permeabilization: Use PFA/Triton X-100.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: SLC9B1
Alternate Names
sodium/hydrogen exchanger-like domain-containing protein 1, solute carrier family 9, subfamily B (cation proton antiporter 2), member 1
Gene Symbol
SLC9B1
Additional SLC9B1 Products
Product Documents for SLC9B1 Antibody
Product Specific Notices for SLC9B1 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...